AAAAAA

   
Results: 1-10 |
Results: 10
A direct determination of thymidine triphosphate concentrations without dephosphorylation in peripheral blood mononuclear cells by LC/MS/MS
Authors: Chi, JD Jayewardene, A Stone, J Gambertoglio, JG Aweeka, FT
Citation: Jd. Chi et al., A direct determination of thymidine triphosphate concentrations without dephosphorylation in peripheral blood mononuclear cells by LC/MS/MS, J PHARM B, 26(5-6), 2001, pp. 829-836
An LC-MS-MS method for the determination of indinavir, an HIV-1 protease inhibitor, in human plasma
Authors: Jayewardene, AL Kearney, B Stone, JA Gambertoglio, JG Aweeka, FT
Citation: Al. Jayewardene et al., An LC-MS-MS method for the determination of indinavir, an HIV-1 protease inhibitor, in human plasma, J PHARM B, 25(2), 2001, pp. 309-317
Drug concentration monitoring of immunosuppressive agents - Focus on tacrolimus, mycophenolate mofetil and sirolimus
Authors: Tsunoda, SM Aweeka, FT
Citation: Sm. Tsunoda et Ft. Aweeka, Drug concentration monitoring of immunosuppressive agents - Focus on tacrolimus, mycophenolate mofetil and sirolimus, BIODRUGS, 14(6), 2000, pp. 355-369
Liquid chromatographic determination of urinary 6 beta-hydroxycortisol to assess cytochrome p-450 3A activity in HIV positive pregnant women
Authors: Homma, M Beckerman, K Hayashi, S Jayewardene, AL Oka, K Gambertoglio, JG Aweeka, FT
Citation: M. Homma et al., Liquid chromatographic determination of urinary 6 beta-hydroxycortisol to assess cytochrome p-450 3A activity in HIV positive pregnant women, J PHARM B, 23(4), 2000, pp. 629-635
Pharmacokinetics of indinavir in HIV-positive pregnant women
Authors: Hayashi, S Beckerman, K Homma, M Kosel, BW Aweeka, FT
Citation: S. Hayashi et al., Pharmacokinetics of indinavir in HIV-positive pregnant women, AIDS, 14(8), 2000, pp. 1061-1062
Antiviral therapy for HIV patients with renal insufficiency
Authors: Jayasekara, D Aweeka, FT Rodriguez, R Kalayjian, RC Humphreys, MH Gambertoglio, JG
Citation: D. Jayasekara et al., Antiviral therapy for HIV patients with renal insufficiency, J ACQ IMM D, 21(5), 1999, pp. 384-395
Effect of renal disease and hemodialysis on foscarnet pharmacokinetics anddosing recommendations
Authors: Aweeka, FT Jacobson, MA Martin-Munley, S Hedman, A Schoenfeld, P Omachi, R Tsunoda, S Gambertoglio, JG
Citation: Ft. Aweeka et al., Effect of renal disease and hemodialysis on foscarnet pharmacokinetics anddosing recommendations, J ACQ IMM D, 20(4), 1999, pp. 350-357
The penetration of anti-infectives into the central nervous system
Authors: Kearney, BP Aweeka, FT
Citation: Bp. Kearney et Ft. Aweeka, The penetration of anti-infectives into the central nervous system, NEUROL CLIN, 17(4), 1999, pp. 883
Pharmacokinetics of fosphenytoin in patients with hepatic or renal disease
Authors: Aweeka, FT Gottwald, MD Gambertoglio, JG Wright, TL Boyer, TD Pollock, AS Eldon, MA Kugler, AR Alldredge, BK
Citation: Ft. Aweeka et al., Pharmacokinetics of fosphenytoin in patients with hepatic or renal disease, EPILEPSIA, 40(6), 1999, pp. 777-782
Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis
Authors: Brody, SR Humphreys, MH Gambertoglio, JG Schoenfeld, P Cundy, KC Aweeka, FT
Citation: Sr. Brody et al., Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis, CLIN PHARM, 65(1), 1999, pp. 21-28
Risultati: 1-10 |